Chlordiazepoxide

Indications

• FDA-approved for mild to moderate anxiety, for severe anxiety disorders, and for preoperative apprehension and anxiety in adults.
• FDA-approved for symptomatic relief of acute alcohol withdrawal, where its long half-life provides a smooth self-tapering effect.
• Guidelines from ASAM support it as a first-choice agent for alcohol withdrawal in patients with preserved hepatic function.
• Marketed in fixed combination with clidinium for adjunctive treatment of peptic ulcer disease and irritable bowel syndrome.
• Off-label for benzodiazepine cross-tapering and detoxification schedules where gradual, forgiving pharmacokinetics are an advantage.
• Not appropriate as maintenance therapy for anxiety disorders; SSRIs, SNRIs and psychotherapy carry the long-term treatment per guideline.

Mechanism of action

• Positive allosteric modulator at the GABA-A benzodiazepine site, raising chloride channel opening frequency in the presence of GABA.
• Cross-tolerance with alcohol at the GABA-A receptor is the pharmacologic basis for substituting it during alcohol withdrawal.
• Suppresses the glutamatergic and autonomic hyperexcitability that emerges when chronic alcohol inhibition is abruptly removed.
• Long-lived active metabolites maintain receptor occupancy for days, blunting symptom breakthrough between doses and easing the taper.
• Non-selective subunit binding yields anxiolysis together with sedation, ataxia, amnesia and anticonvulsant protection against withdrawal seizures.

Pharmacokinetics

• Well absorbed orally with peak concentrations at 1-4 hours; intramuscular absorption is slow and erratic and should not be relied on.
• Parent half-life is 24-48 hours, and the active metabolites desmethylchlordiazepoxide, demoxepam and nordiazepam extend to about 100 hours.
• Oxidized by CYP3A4 and CYP2C19 through a chain of active intermediates before glucuronidation, so hepatic function drives clearance.
• In cirrhosis and in older adults, half-life can more than double and metabolites accumulate for a week, producing delayed oversedation.
• Because it requires hepatic oxidation, lorazepam or oxazepam are preferred for withdrawal management in significant liver disease.

Dosing

• Mild to moderate anxiety: 5-10 mg PO three or four times daily; severe anxiety disorders 20-25 mg three or four times daily.
• Alcohol withdrawal: 50-100 mg initially, repeated as needed until agitation is controlled, to a labeled maximum of 300 mg/day.
• A common symptom-triggered protocol gives 50-100 mg every 6 hours guided by CIWA-Ar score, tapering as autonomic signs settle.
• A fixed-dose alternative is 50 mg every 6 hours for four doses, then 25 mg every 6 hours for eight doses, with breakthrough doses allowed.
• Older adults and debilitated patients: start at 5 mg two to four times daily; children over 6 years may start at 5 mg two to four times daily.
• Taper by 10-25 percent per week after prolonged use; abrupt discontinuation risks withdrawal seizures, delirium and death.

Adverse effects

• Drowsiness, ataxia and confusion are the most frequent effects, particularly in older adults and at the higher withdrawal doses.
• Oversedation and respiratory depression accumulate over days because active metabolites keep building until steady state is reached.
• Falls, hip fracture and delirium in older adults, with the risk extending well beyond the last dose given the long metabolite half-lives.
• Paradoxical excitation, rage reactions and disinhibition, described more often with chlordiazepoxide than with shorter-acting agents.
• Rare hepatic dysfunction, jaundice and blood dyscrasias including agranulocytosis have been reported during prolonged therapy.
• Additive respiratory depression and death with opioids or alcohol; withdrawal after chronic use includes seizures and can be fatal.

Monitoring

• Use CIWA-Ar or a comparable validated scale to drive symptom-triggered dosing and to decide when withdrawal treatment can stop.
• Watch for accumulating sedation on days 2-4 of treatment, since steady state lags the first dose by roughly a week.
• Obtain LFTs and assess for cirrhosis before choosing this agent; switch to lorazepam or oxazepam if hepatic function is impaired.
• Give thiamine before glucose in alcohol withdrawal, and check magnesium, potassium and phosphate along with a metabolic panel.
• Periodic CBC and liver enzymes are advised during prolonged therapy given rare dyscrasias and hepatic reactions.

Interactions

• Additive respiratory depression and overdose death with opioids; also with alcohol, gabapentinoids, antipsychotics and other sedatives.
• Strong CYP3A4 inhibitors such as ketoconazole, ritonavir and clarithromycin increase exposure and prolong an already long half-life.
• Rifampin, carbamazepine and phenytoin induce clearance and can precipitate breakthrough withdrawal symptoms or seizures.
• The clidinium combination adds anticholinergic burden and is contraindicated in glaucoma, prostatic hypertrophy and bladder obstruction.
• Contraindicated in known benzodiazepine hypersensitivity and to be avoided in severe respiratory insufficiency and untreated sleep apnea.

Special populations

• Pregnancy: an increased risk of congenital malformations with first-trimester exposure has been suggested; late exposure causes neonatal withdrawal.
• Lactation: long-acting metabolites accumulate in the nursing infant; lorazepam is a better choice if a benzodiazepine is required.
• Pediatrics: not recommended below 6 years of age, and rarely appropriate above it outside specialist supervision.
• Older adults: the AGS Beers Criteria advise avoiding benzodiazepines, and this long-acting agent is a particularly poor geriatric choice.
• Hepatic impairment: avoid in cirrhosis; lorazepam, oxazepam and temazepam bypass oxidative metabolism and are the safer substitutes.

Clinical pearls

• Long half-life self-tapers alcohol withdrawal but keeps accumulating for days in older patients.
• Switch to lorazepam or oxazepam once cirrhosis or significant hepatic impairment is present.
• Intramuscular absorption is erratic, so use the oral route unless there is no alternative.